Paul Severson
4PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 07, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.Tadashi Manabe, Hannah C Bergo, Qingtian Li
|Nov 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies.Tadashi Manabe, Hannah C Bergo, Qingtian Li
|Nov 17, 2025
RAF inhibitors activate the integrated stress response by direct activation of GCN2.Rebecca Gilley, Andrew M Kidger, Graham Neill
|Apr 11, 2024
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.Benjamin Garmezy, Mitesh J Borad, Rastilav Bahleda
Pageof 1
Frequent Collaborators
3 joint publications
Shumei Kato
2 joint publications
Nicole Zhang
2 joint publications
Joel W Neal
2 joint publications
Wei Wu
2 joint publications
Catherine Lee
2 joint publications
Kathryn Grandinetti
2 joint publications
Tadashi Manabe
2 joint publications
Trever G Bivona
1 joint publications
Mitesh J Borad
1 joint publications
Li-Tzong Chen
